Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/SANTHERA-PHARMACEUTICALS--195471/news/Santhera-Announces-Completion-of-ReveraGen-s-Long-Term-Extension-Study-with-Vamorolone-in-Duchenne-30707855/?utm_source=whatsapp&utm_medium=social&utm_campaign=share